Comparison of Fluorescein plus blue dye and blue dye alone in sentinel lymph node biopsy of breast cancer patients after neoadjuvant chemotherapy
Phase 3
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2020/10/028337
- Lead Sponsor
- AIIMS Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Post NACT, node negative breast cancer patients who are planned for surgery
2.Those who are accepted to participate in the study and gives consent
3.Between 18 and 90 years of age.
4.ECOG performance status 0-1
Exclusion Criteria
1.Prior surgical procedures that have the potential to substantially alter the lymphatic drainage pattern from the primary tumor to the lymph node basin.
2.Allergy to fluorescein /methylene blue
3.Pregnant or lactating women
4.Renal failure / Renal parenchymal disease patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method